AzTrials
AzTrials

Third Degree HemorrhoidsPhase 4NCT01263431

Comparison Between Excisional Hemorrhoidectomy and Haemorrhoidal Dearterialisation With Anopexy

A Phase 4 study testing Hemorrhoidectomy and Hemorrhoidal dearterialization in people with Third Degree Hemorrhoids, run by Scientific Institute San Raffaele at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim of the study is to compare short term results of 2 surgical treatment for grade 3 hemorrhoidal disease, namely: pain and postoperative morbidity,complications and effectiveness within 30 days, re-starting daily and working activity, patients' satisfaction Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Third Degree Hemorrhoids
What is being tested?
Hemorrhoidectomy and Hemorrhoidal dearterialization
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteItaly
Study dates
Jul 2010to Apr 2012
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged 18-80, candidate to surgery for 3rd degree hemorrhoids

Who cannot join

  • Previous anal surgery or pelvic radiotherapy
  • Fecal incontinence or obstructed defecation
  • IBD, IBS

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • San Raffaele Scientific Institute

    Milan, 20132

Other trials in Italy

About this study

Official title: Prospective Randomized Trial on Surgical Treatment of Grade 3 Hemorrhoids: Hemorrhoidectomy Versus Doppler-guided Transanal Haemorrhoidal Dearterialisation and Anopexy

Aim of the study is to compare short term results of 2 surgical treatment for grade 3 hemorrhoidal disease, namely: pain and postoperative morbidity,complications and effectiveness within 30 days, re-starting daily and working activity, patients' satisfaction

Read the detailed description

Excisional haemorrhoidectomy is burdened by severe postoperative pain. For this reason less painful treatments have been developed, such as Doppler-guided haemorrhoidal artery ligation and stapled anopexy. Both techniques seem to be safe, causing little postoperative pain. A combination of the two techniques could possibly treat both bleeding and prolapse with minimal discomfort

Being tested
Hemorrhoidectomy, Hemorrhoidal dearterialization
Keywords
Hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HemorrhoidectomyProcedure or surgery

    Each of the main haemorrhoid is dissected and the apex is ligated and then cut, near to the dentate line

  • Hemorrhoidal dearterializationProcedure or surgery

    A special instrument (THD, G.F., Medical Division, Correggio, Italy )with an incorporated Doppler probe is used to detected the six terminal branches of the superior rectal artery which are ligated above the dentate line, then a running suture is performed in order to obtain a mucopexy

Study groups in NCT01263431
Study groupRoleWhat they receive
HemorrhoidectomyActive comparatorExcision of hemorrhoid cushions
Receives: Procedure: Hemorrhoidectomy
Hemorrhoidal dearterializationExperimentalLigation of therminbal branches oh hemorrhoid arteries
Receives: Procedure: Hemorrhoidal dearterialization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. postoperative pain

    Measured: 1 week

Secondary outcomes (4)
  1. postoperative morbidity

    Measured: 30 days

  2. resumption of working activity

    Measured: 30 days

  3. patient's satisfaction

    Measured: 30 days

  4. Relapse

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2010 (estimated)
  2. Study startJul 2010
  3. Primary completionApr 2011
  4. Study completionApr 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01263431
Sponsor's protocol ID
Emorroidi grado 3
Status last verified
Jan 2015
First submitted
17 Dec 2010
Last updated
22 Jan 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • De Nardi P, Capretti G, Corsaro A, Staudacher C. A prospective, randomized trial comparing the short- and long-term results of doppler-guided transanal hemorrhoid dearterialization with mucopexy versus excision hemorrhoidectomy for grade III hemorrhoids. Dis Colon Rectum. 2014 Mar;57(3):348-53. doi: 10.1097/DCR.0000000000000085.

    PubMed 24509458

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Hemorrhoidectomy and Hemorrhoidal dearterialization in people with Third Degree Hemorrhoids, run by Scientific Institute San Raffaele at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

postoperative pain (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01263431, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in